Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

Market Cap	26.03B +9.9%
Revenue (ttm)	157.71B +5.7%
Net Income	2.79B +36.2%
EPS	0.55 +34.2%
Shares Out	4.99B
PE Ratio	9.50
Forward PE	11.61
Dividend	0.20 (3.80%)
Ex-Dividend Date	Jun 17, 2025

Volume	39,456,400
Average Volume	72,010,406
Open	5.28
Previous Close	5.27
Day's Range	5.21 - 5.32
52-Week Range	4.57 - 5.84
Beta	0.32
RSI	46.19
Earnings Date	Apr 28, 2026

About SHA:600998

Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added services; and digital logistics and supply chain solutions. The company was founded in 1999 and is headquartered in Wuhan, China.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 30,169
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600998

Financial Performance

In 2024, SHA:600998's revenue was 151.81 billion, an increase of 1.11% compared to the previous year's 150.14 billion. Earnings were 2.51 billion, an increase of 15.33%.